USFDA completes inspection at Indoco Remedies’ API manufacturing facility

19 Sep 2025 Evaluate

The United States Food and Drug Administration (USFDA) has successfully completed inspection at Indoco Remedies’ Active Pharmaceutical Ingredients (API) manufacturing facility at Patalganga, Navi Mumbai. The inspection concluded with zero form 483 observations, reflecting the company's commitment to the highest standards of quality, regulatory compliance and operational excellence.

This successful USFDA inspection is a testament to the strong quality culture and compliance in every process and every product. The company remains committed to strengthening its systems to deliver safe and efficacious medicines across the globe. 

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


Indoco Remedies Share Price

251.80 -0.10 (-0.04%)
05-Dec-2025 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.00
Dr. Reddys Lab 1273.70
Cipla 1521.00
Zydus Lifesciences 931.60
Lupin 2093.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×